CORC

在结果中检索

CORC

浏览/检索结果: 共15条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Current status and dilemma of second-line treatment in advanced pancreatic cancer: is there a silver lining? 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Hua, Jie;  Shi, Si;  Liang, Dingkong;  Liang, Chen;  Meng, Qingcai
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer 期刊论文
THORACIC CANCER, 2018, 卷号: 9, 期号: 9
作者:  Lv, Chunxin;  Liu, Xiuju;  Zheng, Qiwen;  Chen, Hanxiao;  Yang, Xue
收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05
Cost-effectiveness analysis of sensitive relapsed small-cell lung cancer based on JCOG0605 trial 期刊论文
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 卷号: Vol.20 No.6, 页码: 768-774
作者:  Zhou, K.;  Wen, F.;  Zhang, P.;  Zhou, J.;  Zheng, H.
收藏  |  浏览/下载：14/0  |  提交时间：2019/02/28
Analysis of topoisomerase I expression and identification of predictive markers for efficacy of topotecan chemotherapy in small cell lung cancer 期刊论文
2018, 卷号: 9, 期号: 9, 页码: 1166-1173
作者:  Lv, Chunxin;  Liu, Xiuju;  Zheng, Qiwen;  Chen, Hanxiao;  Yang, Xue
收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03
S-1 monotherapy versus S-1 combination therapy in gemcitabine-refractory advanced pancreatic cancer: A meta-analysis (PRISMA) of randomized control trials 期刊论文
MEDICINE, 2017, 卷号: 96, 期号: 30
作者:  Zhong, Sheng;  Qie, Shuai;  Yang, Liu;  Yan, Qi;  Ge, Linna
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Efficacy and safety of Endostar (recombinant human endostatin hormone) combined with docetaxel as second-or third-line therapy for patients with non-small-cell lung cancer 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 卷号: 10, 期号: 1
作者:  Ji, Dongmei;  Wang, Jialei;  Yu, Hui;  Wu, Xianghua;  Wang, Huijie
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Efficacy and Safety of Nab-Paclitaxel as Second-line Chemotherapy for Locally Advanced and Metastatic Non-small Cell Lung Cancer 期刊论文
ANTICANCER RESEARCH, 2017, 卷号: 37, 期号: 8, 页码: 4687-4691
作者:  Wong, Wenjing;  Sun, Ping;  Mu, Zhengbin;  Liu, Jiannan;  Yu, Caiyan
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/12
Gemcitabine Plus Vinorelbine as Second-Line Therapy in Patients With Metastatic Esophageal Cancer Previously Treated With Platinum-Based Chemotherapy 期刊论文
ONCOLOGY RESEARCH, 2016, 卷号: 24, 期号: 2, 页码: 129-135
作者:  Wang, Yue-shen;  Tian, Jing;  Han, Yong;  Han, Shu-mei;  Shi, Sheng-bin
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/16
A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer 期刊论文
MEDICAL ONCOLOGY, 2015, 卷号: 32, 期号: 1
作者:  Cao, Ranhua;  Zhang, Shuai;  Ma, Dedong;  Hu, Likuan
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/17
A multi-center randomized phase II clinical study of bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) compared with FOLFIRI alone as second-line treatment for Chinese patients with metastatic colorectal cancer 期刊论文
Medical oncology, 2015, 期号: 1
作者:  Cao, Ranhua;  Zhang, Shuai;  Ma, Dedong;  Hu, Likuan
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/17

©版权所有 ©2017 CSpace - Powered by CSpace